Scorer, Paul
Scott, Marietta
Lawson, Nicola
Ratcliffe, Marianne J.
Barker, Craig
Rebelatto, Marlon C.
Walker, Jill
Funding for this research was provided by:
AstraZeneca
Article History
Received: 19 January 2018
Accepted: 5 July 2018
First Online: 24 July 2018
Ethics approval and consent to participate
: All samples were commercially acquired from the following sources: Avaden, Asterand, ProteoGenex, and Tissue Solutions. AstraZeneca has a governance framework and processes in place to ensure that commercial sources have appropriate patient consent and ethical approval in place for collection of the samples for research purposes, including use by for-profit companies. The AstraZeneca Biobank in the UK is licensed by the Human Tissue Authority (Licence No. 12109) and has National Research Ethics Service Committee (NREC) approval as a Research Tissue Bank (RTB) (REC No 17/NW/0207), which covers the use of the samples for this project.
: Not applicable; no individual person’s data presented.
: PS, MS, NL, CB and JW are employees of AstraZeneca and hold stocks or shares in AstraZeneca. MJR is an employee of AstraZeneca. MCR is an employee of MedImmune LLC and holds stocks or shares in AstraZeneca.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.